智通财经7月10日电，有机硅概念盘中持续走高，硅宝科技、晨化股份涨超10%，此前晨光新材、宏柏 新材涨停，东岳硅材、润禾材料、合盛硅业涨幅靠前。消息面上，7月7日，陶氏化学宣布关闭英国巴里 工厂的基础硅氧烷设施，涉及14.5万吨DMC产能，预计关闭工作将于2026年年中开始，2027年底前完 成。陶氏退出的供给缺口有望进一步加大国内企业的出口需求，行业供需有望加速进入转换窗口期。 有机硅概念持续拉升 硅宝科技、晨化股份双双涨超10% ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup News Service, Gracenote... Read more Abou ...

Verizon has the lowest share price among the Dow's 30 components -- and that's a dangerous place to be in a share price-weighted index. In May, the iconic Dow Jones Industrial Average (^DJI -0.37%) celebrated its 129th "birthday" since its official inception. Over this time, we've witnessed the Dow blossom from an industrial stock-dominated 12- component index to one that now houses 30 diverse, time-tested, multinational businesses. Although the Dow Jones is still viewed as a barometer of Wall Street's heal ...

Key Takeaways DOW will close three upstream assets in Germany and the U.K. by the end of 2027. The move aims to lower exposure to merchant sales and cut energy-intensive operations. DOW expects $200M EBITDA by 2029, with $500M in cash costs over four years.Dow Inc. (DOW) recently announced that its board of directors has approved the closure of several facilities across its global operations. This is part of Dow’s continued implementation of the European asset actions outlined in April 2025. This includes ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Some large dividend stocks are still near the year's low and bring their dividend yield to an "astronomical" level in the face value, which may prevent the value investors from stepping in because they worry about aAdvanced education in economics, business management and engineering. Professional experience with product management and development in high tech industry, including advisory with multiple fintech startups. Have been investing in growth companies since 1998. Recent interest of investment also in ...

Market Overview - U.S. stocks experienced a decline, with the Dow Jones index falling over 400 points, down 1% to 44,379.69, NASDAQ down 0.85% to 20,426.99, and S&P 500 down 0.39% to 6,255.16 [1] - In commodities, oil increased by 0.7% to $67.44, while gold decreased by 0.5% to $3,325.80, silver fell 0.8% to $36.795, and copper dropped 2.7% to $5.0025 [5] Company News - Cogent Biosciences, Inc. announced positive topline results from Part 2 of the SUMMIT trial for bezuclastinib, showing significant improvements across primary and key secondary endpoints [2] - Mustang Bio, Inc. shares surged 319% to $4.99 after receiving FDA Orphan Drug Designation for MB-101 in astrocytomas and glioblastoma [9] - Artelo Biosciences, Inc. saw a 79% increase in shares to $17.98 following preclinical efficacy results with ART12.11 in a stress-induced depression model [9] - LogProstyle Inc. shares rose 155% to $2.08 after reporting year-over-year financial growth for FY25 [9] - Core Scientific, Inc. shares dropped 21% to $14.21 after CoreWeave announced plans to acquire the company in an all-stock deal [9] - Jasper Therapeutics, Inc. shares fell 51% to $3.2964 after reporting an 89% response rate in its Urticaria study and the decision to halt the program [9] - Apogee Therapeutics, Inc. shares decreased by 16% to $40.03 following the release of 16-week data from Part A of the Phase 2 APEX clinical trial for APG777 [9] Regional Market Performance - European shares showed positive movement, with the eurozone's STOXX 600 rising 0.43%, Spain's IBEX 35 Index up 0.43%, London's FTSE 100 gaining 0.01%, Germany's DAX 40 increasing by 1%, and France's CAC 40 up 0.39% [6] - Asian markets closed mixed, with Japan's Nikkei down 0.56%, Hong Kong's Hang Seng down 0.12%, while China's Shanghai Composite gained 0.02% and India's BSE Sensex increased by 0.01% [7]

【DT新材料】 获悉，7月7日， 陶氏 宣布，其董事会已批准关闭三个欧洲上游资产，以应对该地区 面临的结构性挑战并优化盈利能力。 此次关闭的资产包括 ： 据了解，此次关停行动将影响约800个陶氏岗位，这也是公司今年1月宣布的 10亿美元 成本节约行动 的一部分，其中包括在全球范围内裁员约 1,500名 陶氏职位。 陶氏预计，这些资产的关闭将从2026年开始提升运营EBITDA（息税折旧及摊销前利润），到2027 年年底将达到约 2亿美元 目标的 50% ，并在2029年全面交付。四年的现金支出约为 5亿美元 。 据悉， 此次三家工厂关停的决定是陶氏自2023年以来发起的20多项"资产行动"的延续。此前公司已 于2024年先后关闭了 阿根廷圣洛伦索的聚醚多元醇工厂 、 中国台湾南岗工业区的烷氧基化工厂 ， 并出售了 软包装粘合剂业务 （出售给 阿科玛 ） 等非核心资产。 除了欧洲的三家工厂关停外，今年以来， 陶氏还有多项业务调整： 包装和特种塑料： 位于德国 博伦 的乙烯裂解装置，预计在2025年第四季度关闭。 工业中间产品和基础设施： 位于德国 施科保 的氯碱和乙烯基（CAV）资产，预计在2025年第 四季度 ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...